Gildon Choi

This inventor holds 9 USPTO granted patents and 6 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Korea Research Institute of Chemical Technology, Dong Wha Pharm. Co., Ltd., Sungkyunkwan University. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gildon Choi. Retrieved from https://idiyas.com/inventor/gildon-choi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 6)

% Patents Active = 66.7

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 3(Granted Patents)

Location History:

Daejun, KR (2011)
Daejeon, KR (2012 - 2024)

Company Filing History:

9 out of 651

Korea Research Institute of Chemical Technology

patents

1 out of 6

Dong Wha Pharm. Co., Ltd.

patents

1 out of 1,352

Sungkyunkwan University

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12630511 - Benzamide derivative, preparation method therefor, and pharmaceutical composition comprising same as active ingredient for prevention or treatment of cancer (2026-05-19),

2. 11976059 - Isoindolin-1-on derivative, method for preparing same, and pharmaceutical composition comprising same as effective component for preventing or treating cancer (2024-05-07),

3. 11365215 - Method for preventing, improving, or treating inflammatory bowel disease (2022-06-21),

4. 11253516 - N2,N4-diphenylpyrimidine-2,4-diamine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of cancer (2022-02-22),

5. 11028090 - [1,2,4]Triazolo[4,3-a]quinoxaline derivative, method for preparing same, and pharmaceutical composition for preventing or treating BET protein-related diseases, containing same as active ingredient (2021-06-08),

6. 10647686 - Substituted pyrimidines for preventing or treating cancer and inflammatory diseases (2020-05-12),

7. 8372844 - Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same (2013-02-12),

8. 8236806 - Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same (2012-08-07),

9. 7915405 - 2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives for therapeutic agent of antiinflammatory disease, method thereof for preparation, therapeutic agent for antiinflammatory disease induced by SPC activity containing the same (2011-03-29),

Title: Gildon Choi: Innovator in Pharmaceutical Chemistry

Introduction

Gildon Choi is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating various medical conditions. With a total of eight patents to his name, Choi's work focuses on innovative solutions for complex health issues.

Latest Patents

Choi's latest patents include an isoindolin-1-on derivative, which is a method for preparing the compound and a pharmaceutical composition that utilizes it as an effective component for preventing or treating cancer. This invention highlights the isoindolin-1-on derivative's high inhibitory effect on EGFR mutations, making it a promising candidate for treating EGFR-mutated tumors. Additionally, he has developed a method for preventing, improving, or treating inflammatory bowel disease through pyrrolidine carboxamido derivatives and their optical isomers, which can effectively address inflammatory conditions.

Career Highlights

Throughout his career, Gildon Choi has worked with esteemed institutions such as the Korea Research Institute of Chemical Technology and Sungkyunkwan University. His research has led to advancements in pharmaceutical applications, showcasing his dedication to improving health outcomes through innovative chemistry.

Collaborations

Choi has collaborated with notable colleagues, including Kwangho Lee and Jae Yang Kong, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Gildon Choi's contributions to pharmaceutical chemistry through his patents and collaborations demonstrate his commitment to advancing medical science. His innovative approaches to treating cancer and inflammatory diseases highlight the importance of research in improving health outcomes.

Profile summary based on public USPTO records.